Imagine finally getting the prescription that could end your hot flashes, brain fog, and sleepless nights…
…and then spending weeks driving pharmacy to pharmacy trying to actually find it.
That's the reality for millions of women in America right now.
The culprit? A tiny, sticker-sized estrogen patch.
In just two years, estrogen patch prescriptions have more than doubled.
Doctors are spending hours every single day just hunting down inventory for their patients.
"Between my nurse, patients' pharmacists and myself, we are doing this pretty much every day," one Iowa physician said. She laughed when asked how much time it eats up.
Because what else can you do.
For over two decades, women were warned away from hormone therapy.
A 2002 study spooked everyone. Black box warning slapped on the label. Breast cancer fears. Dementia fears. A whole generation told to just tough it out.
Turns out… the study was flawed. Participants were older than typical HRT users. The risks were wildly overstated.
On November 10, 2025, the FDA finally pulled those black box warnings off menopausal hormone therapy.
And the floodgates opened.
This wasn't a pharma marketing push.
It was women talking to women.
Oprah brought it to prime time. Creators flooded TikTok and Instagram with their HRT journeys. Group chats lit up with "wait, I don't have to suffer through this?"
Hims & Hers smelled it early — launched a menopause arm under Hers in October. Interest has tripled since.
Here's the frustrating part.
Transdermal patches aren't pills. They're highly complex to manufacture.
Sandoz called it "unprecedented demand that cannot be fully met at present."
Experts predict it'll take at least a year — maybe two — before supply catches demand.
A generation of women was told their suffering was the price of safety.
It wasn't.
Now they're demanding the relief that was always there — faster than the system can manufacture it.
That's not a supply chain problem.
That's a reckoning.
That's all for now!
